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Abstract
Pseudomonas aeruginosa is the causative agent of chronic respiratory infections and is an
important pathogen of cystic fibrosis patients. Adaptive mutations play an essential role for
antimicrobial resistance and persistence. The factors that contribute to bacterial mutagene-
sis in this environment are not clear. Recently it has been proposed that cationic antimicro-
bial peptides such as LL-37 could act as mutagens in P. aeruginosa. Here we provide
experimental evidence that mutagenesis is the product of a joint action of LL-37 and free
iron. By estimating mutation rate, mutant frequencies and assessing mutational spectra in
P. aeruginosa treated either with LL-37, iron or a combination of both we demonstrate that
mutation rate and mutant frequency were increased only when free iron and LL-37 were
present simultaneously. Colistin had the same effect. The addition of an iron chelator
completely abolished this mutagenic effect, suggesting that LL-37 enables iron to enter the
cells resulting in DNA damage by Fenton reactions. This was also supported by the obser-
vation that the mutational spectrum of the bacteria under LL-37-iron regime showed one of
the characteristic Fenton reaction fingerprints: C to T transitions. Free iron concentration in
nature and within hosts is kept at a very low level, but the situation in infected lungs of cystic
fibrosis patients is different. Intermittent bleeding and damage to the epithelial cells in lungs
may contribute to the release of free iron that in turn leads to generation of reactive oxygen
species and deterioration of the respiratory tract, making it more susceptible to the infection.
Author Summary
Cationic antimicrobial peptides (cAMPs) are small proteins naturally produced by the
immune system to limit bacterial growth mainly through pore formation in the mem-
brane. It has recently been suggested that sub-inhibitory concentrations of cAMPs pro-
mote bacterial mutagenesis, similarly to antibiotics. However, we previously reported that
cAMPs do not increase mutation rate and do not activate bacterial stress responses. Here
we resolve this contradiction. We report that free iron in the culture medium increases
mutagenesis in the presence of cAMPs. We show that sub-inhibitory concentrations of
cAMPs facilitate entry of free iron into bacterial cells, where it interacts with hydrogen per-
oxide, thereby resulting in production of DNA-damaging reactive oxygen species and
increased mutagenesis. Moreover, these results may have clinically-relevant implications:
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while very little free iron is normally present in healthy individuals, this is not the case in
patients suffering from cystic fibrosis, where elevated bacterial mutagenesis promotes anti-
biotic resistance and contributes to persistence and severity of infection. Thus, an inter-
vention aimed at reduction of free iron in the lungs could reduce the cAMPs-facilitation of
iron-mediated mutagenesis; hence antibiotic resistance and pathoadaptation.
Introduction
Pseudomonas aeruginosa is an important opportunistic pathogen involved in chronic respira-
tory and hospital-acquired infections [1]. In cystic fibrosis (CF) patients, one of the most com-
mon genetic diseases in humans, this bacterium causes chronic lung infections that result in
significant morbidity and mortality [2]. P. aeruginosa infections are difficult to treat due the
inherent resistance to many drug classes, its ability to acquire resistance, via mutations, to all
relevant treatments and its high and increasing rates of resistance locally [3].
Mutagenesis plays a crucial role in adaptation of this pathogen for persistence and antibiotic
resistance acquisition in CF [4], being found a high proportion of hypermutable bacteria
among P. aeruginosa isolates [5]. Recently, Limoli et al [6] reported an increased mutant fre-
quency after treatment of P. aeruginosa with the human cationic peptide LL-37. Based on this
finding they proposed that cationic peptides elevated bacterial mutation rates. In a recent
study, we reported mutation rates of E. coli in the presence of cationic antimicrobial peptides
(cAMPs) and antibiotics. LL-37 was present in the panel of AMPs that we tested and we did
not find any increase in mutation rates. We also used transcription reporter assays and
qRT-PCR and showed that none of the AMPs elicited the main mutagenic stress pathways of
bacteria SOS or rpoS [7].
Here, we aim to resolve this apparent contradiction based on the observation that the differ-
ent studies used different media. Limoli et al. [6] used M63 for P. aeruginosa and LB for E. coli,
while we used non-cation adjusted Mueller-Hinton Broth (MHB), commonly used for cAMP
susceptibility testing. The most striking difference in culture media between the two studies is
that both, M63 [8] and LB are iron-rich [9,10], while MHB is not [11]. Fe2+ catalyses hydroxyl
radical formation by reacting with hydrogen peroxide both intra- and extra-cellularly, the Fen-
ton reaction [12]. Without free iron hydrogen peroxide reactivity is low at physiological pH
and iron metabolism is strictly controlled to avoid DNA and other damage caused by oxygen
radicals [13,14]. In most natural situations iron is in short supply, but in cystic fibrosis [15,16]
due to accult bleeding of highly vascularised lung tissue and haemoptysis particularly during
acute exacerbations, and damage of the respiratory tract epithelium where Fe2+ is present inter-
mittently. Although ferrous iron is prone to oxidation, the anaerobic growth of at to high den-
sity of bacteria [17] may contribute to stabilise this metal in the reduced state.
Many cationic antimicrobial peptides change membrane permeability properties [18], and
this led us to hypothesize that sub-inhibitory concentrations of LL-37 increase uncontrolled
iron transport from the extracellular space to the cytoplasm without the intervention of the
bacterial iron trafficking system. An intracellular surplus of iron should then result in DNA
damage caused by the Fenton reaction.
Here, we (i) estimate the mutation rate of P. aeruginosa in the presence of LL-37, iron or
both; (ii) we then investigate the hypothesis that ferrous iron (Fe+2) is causal to an increase in
mutation rate and that LL-37 and colistin facilitate this process; and finally (iii) we investigate
the mutational spectra to find out if promoted mutations match with any of the molecular sig-
natures of Fenton reactions.
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Results and Discussion
Mutation rate is increased in the presence of ferrous Fe2+ and LL-37
First we determined the mutation rate of P. aeruginosa using a fluctuation assay, in the presence of
either LL-37 (32 μg/ml), Fe2+ (40μM), or both (Fig 1). Mutation rate was only increased when LL-
37 and Fe2+were added simultaneously, while addition of LL-37 or Fe2+ separately did not produce
the same effect. To investigate the effect of different concentrations of LL-37 and Fe2+, we esti-
mated mutant frequencies. None of the LL-37 concentrations tested, ranging from 4 to 32 μg/ml,
yielded any detectable changes in mutant frequency (S1 Fig). Fe2+ alone, at different concentra-
tions, also did not increase the mutant frequencies in comparison with the control group (S2 Fig).
Subsequently, we assayed the MIC50 (32 μg/ml) of LL-37 with several iron concentrations
and measured the impact on rifampicin mutant frequency of P. aeruginosa strain PAO1. We
found that added concentrations of 10, 20, 40 and 80 μM of Fe2+, increased the mutant fre-
quency between three to five times (S3 Fig).
Limoli et al. [6] observed increased mutant frequencies in both, P. aeruginosa and E. coli,
proposing that LL-37 induces mutagenesis in these bacteria. Taken at face value, this contrasts
with our work, where we did not find such effect in E. coli [7]. P. aeruginosa in the Limoli et al.
study however, was cultured in an iron-rich medium, M63 [8], which contains 0.5 mg of iron
sulphate per litre (Fe2+). To confirm the results in a different bacterial model, the experiment
was repeated with E. coli using LB as a culture medium. However, LB is also iron-rich (~16 μM
of iron) [9,10]. In these experiments, just before the treatment with LL-37 in a saline solution,
bacteria were washed. It has, however, been shown that Gram-negative bacteria can actively
accumulate iron in the periplasmic space [19]. This led us to hypothesise that sub-lethal con-
centrations of cationic antimicrobial peptides can facilitate iron transport into the cells.
LL-37 facilitates mutagenesis but iron is causal
To confirm that iron is causing the observed increase in mutagenesis, we first repeated the
assay in the presence of an iron chelator, 2–20 bipyridyl. 2–20 bipyridyl completely abolished
Fig 1. The joint action of LL-37 and ferrous iron induces an increase in the mutation rate of P.
aeruginosa. No changes occur when LL-37 or iron are added to the culture separately. Error bars represent
95% confidence intervals for mutation rates.
doi:10.1371/journal.pgen.1005546.g001
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the increase in mutant frequency in the tested concentration of LL-37+Fe2+ combination. The
sole action of the chelator plus Fe2+ did not increase the mutant frequency (Fig 2).
Bacteria have a number of mechanisms to keep free iron as low as possible inside the cell.
One of these is Dps, a natural iron chelating protein. To confirm the results obtained with 2–20
bipyridyl, we used a Dps over-expressing strain by cloning the dps gene into a multi-copy plas-
mid under a constitutive promoter. The mutagenesis was not completely reverted in compari-
son with non-treated controls, but there was a 1.8 fold-reduction (Fig 2).
The iron uptake assay showed that there was a significant difference (Mann-Whitney U test,
P = 0.00015) in total iron content in bacterial cells between LL-37+ Fe2+ (17.50 ± 5.10 nmoles/
ml, mean ± standard deviation) and iron alone (5.65 ± 4.13 nmoles/ml, mean ± standard devia-
tion) treatments after 30 minutes of incubation, indicating that LL-37 indeed promotes a non-
physiological free iron entrance.
We also tested a further AMP: colistin, which is of bacterial origin, and is one of the most
effective agents against P. aeruginosa in CF infections [20]. We treated cultures of P. aeruginosa
PAO1 with MIC50 of colistin (1.8 μg/ml) in high and low concentrations of iron in the media.
The effects of colistin were very similar to the effects we found for LL-37 (Fig 3). Although the
mechanism of action of colistin is not fully understood [21], our results suggest pore forming
mechanism or permeability changes in the cell as likely mechanisms. It has been demonstrated
that colistin promotes the uptake of hydrophilic antibiotics, explaining their synergism with
them [22].
Previous work has suggested that iron is involved in Pseudomonas aeruginosa pathoadapta-
tion and antibiotic resistance acquisition [15]. All experiments were carried out with the more
soluble Fe2+ because ferrous iron is abundant in the CF lung (~39 μM on average for severely
ill patients) and significantly correlates with disease severity [23]. Moreover, iron activates the
two-component signal transduction system BqsRS in P. aeruginosa, which is transcriptionally
active in CF sputum, and promotes tolerance to cationic stressors [24]. This increases the toler-
ance to both host peptides such as LL-37 and colistin, which is administered in CF therapy.
Fig 2. Themutagenesis of LL-37+Fe2+ combination is suppressed by the addition of an iron chelator. This supports the notion that iron is causal in
increasing mutagenesis (A). In the same line, over-expression of Dps, a natural iron chelator in bacteria, also decreases the mutant frequency to rifampicin
(B). Error bars represent 95% confidence intervals for mutant frequencies.
doi:10.1371/journal.pgen.1005546.g002
Cationic Peptides and Iron Mutagenesis in Bacteria
PLOS Genetics | DOI:10.1371/journal.pgen.1005546 October 2, 2015 4 / 16
The newmechanism proposed here has almost certainly important implications. Under specific
pathologies such as cystic fibrosis or other respiratory chronic diseases, iron that is usually in short
supply, is abundant. Disturbances in iron metabolism have been shown to promote evolution of
antibiotic resistance in E. coli [25]. Given that cationic antimicrobial peptides usually induce mem-
brane permeability in all susceptible microbes and Fenton chemistry is universal, the mechanism
we propose here is likely applicable to other AMPs. For example, beta-defensin-2 was shown to
double the mucoid conversion rate, a mutagenic process, of P. aeruginosa [6]. Yet free iron is rarely
available in most physiological situations but for a few pathologies such as cystic fibrosis
Additionally, it has been reported that some cationic antimicrobial peptides interact with
bacterial membrane proteins and delocalise them [26]. It is conceivable then that LL-37 may
interact and interfere with iron transport systems, which in turn may contribute to iron
homeostasis disruption and enhance mutagenesis. This possibility requires additional investi-
gation and will be the goal for future studies.
In the context of cystic fibrosis, the increase in salt concentration may lead to the reduced
activity or complete inactivation of other antimicrobial peptides, as observed for human beta-
defensin-1 [27], while other components could eventually contribute to mutagenesis in the
same way that LL-37 does. Moreover, the PhoP-PhoQ and PmrA-PmrB two-component regu-
latory systems of P. aeruginosamay play an important role in antimicrobial peptide tolerance.
This resistance is reproduced in vitro when magnesium concentrations are low [28]. Our
experimental conditions, where divalent cations are depleted or in low concentrations, seem
comparable. In the light of our results this suggest that bacteria under certain conditions that
elicit the expression of these two component systems alter the lipidA structure resulting in
increased resistance to colistin [29]. The same systems up-regulate ferrous iron uptake which is
mediated by feoAB operon [28,30]. This phenomenon could potentially contribute to saturate
intracellular iron storage systems and to generate an excess of iron that eventually can partici-
pate in Fenton reaction operating by the mechanisms that we propose here.
How would the mechanism we propose here enhance the overall mutation rate of bacterial
populations? In the context of cystic fibrosis, there is a high proportion of hypermutable bacte-
ria due to the inactivation of their DNAmiss-match repair (MMR) genes [31]. We may expect
a synergistic effect of both types of mutagenesis as we proposed in the past for the mutagenic
effect of cystic fibrosis lung environment and the intrinsic mutagenesis of P. aeruginosa [4]. It
Fig 3. Mutagenesis induced by colistin and Fe2+ combination. The mutation rate is only increased if both,
iron and colistin, are present. Error bars represent 95% confidence intervals for mutation rates.
doi:10.1371/journal.pgen.1005546.g003
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can be speculated that iron-mutagenesis can facilitate the rise of mutator bacteria by enhancing
the inactivation of MMR genes. This could then weaken genetic constraints that impede the
evolution of bacteria to resist antibiotics by multiple pathways as previously described [32].
Mutational spectra of iron-induced mutagenesis
The results above strongly suggest that sub-lethal concentrations of cationic antimicrobial pep-
tides facilitate the access of free iron to the cytoplasmic compartment of P. aeruginosa. Given
that the Fenton reaction results in DNA damage [33] and reactive oxygen species (ROS) dam-
ages to the DNA display specific molecular fingerprints, we investigated if there was evidence
of the Fenton reaction effects on the mutational spectrum.
It would be very difficult to investigate the mutational spectrum in rpoB (sub-unit of RNA
polymerase) that confers resistance to rifampicin in P. aeruginosa PAO1. This gene is essential
and detectable mutations are mostly point mutations, which would constrain the analysis to a
few types of changes. We therefore decided to use another strain, PA14, where mutations that
confer resistance to fosfomycin are well characterized [34–36]. Resistance mutations to fosfo-
mycin in P. aeruginosa PA14 depend on a single non-essential locus encoding the glycerol-
3-phosphate transporter GlpT, making it a much better marker for studying the entire reper-
toire of mutations compared to rpoB [36,37] [38].
The treatment of P. aeruginosa P14, which shows a similar sensitivity to LL-37 as the PAO1
strain used above, with the mutagenic combination of LL-37+Fe2+ showed almost a four fold-
increase in mutant frequency (S4 Fig).
To assess how addition of free iron and antimicrobial peptides affect the mutation spectrum
of the glpT gene of PA14 strain we exposed bacteria to either free iron, antimicrobial peptide
LL-37, or both. All of the resulting resistant mutants contained non-synonymous substitutions
or deletions in glpT that potentially affect the stability of GlpT transporter and likely disrupt
the function of the protein (Figs 4, S5 and S6 and S1 Table). LL-37+Fe2+-treated bacteria dis-
played striking differences in mutational spectra when compared to the other treatments (Fig 4
and S1 Table). We used Monte Carlo hypergeometric test implemented in iMARS, a mutation
analysis reporting software [39], to assess the overall differences between mutational spectra.
The probability of the mutational spectra to be the same stood at 0.554706 (P-value confidence
limits 0.531080–0.578) when the iron treatment was compared to LL-37, but was below
0.0000001 when either were compared with LL-37+Fe2+ treatment. Moreover, we found a
mutation hotspot (R93 to W change, 10/20 clones) in the LL-37+Fe2+ treatment group that
was significantly (P = 0.0004, two-tailed Fisher’s exact-test) different from the two other treat-
ments (S2, S3 and S4 Tables). This mutation hotspot is a single nucleotide transition from C to
T, which is one of the most frequent types of mutations caused by ROS [40]. We found that
twelve out of twenty clones from the LL-37+Fe2+ condition had C to T transitions, whereas
none were present in either iron or LL-37- treated bacteria (two-tailed Fisher's exact-test (P<
0.0001) (S7 Fig). It is striking that although several C to T mutations can potentially lead to
glpT inactivation are in principle possible, that the majority are concentrated in a single point.
Such mutation hotspots can be driven by a specific topology on the chromosome [41], or a par-
ticular sequence prone to double strand breaks resulting in mutations after repair [42]. In gen-
eral, observable mutations are the results of mutation-repair balance and not all mutations are
repaired with the same efficiency. A good example in P. aeruginosa is the mutational inactiva-
tion of the anti-sigma factor gene,mucA, with the mutated allelemucA22 most prevalent (25 to
40%). This inactivation seems to be spectrum dependent [43].
Interestingly, C to T transitions were one of the most frequent types of single nucleotides
changes in the genomes of Salmonella typhimurium evolved to increasing concentrations of
Cationic Peptides and Iron Mutagenesis in Bacteria
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LL-37 in modified LB medium short of sodium chloride and anions [44], which is fully consis-
tent with our results.
A number of studies [45–48], which caused some controversy [49–51], suggested that
hydroxyl radicals can be generated as a consequence of antibiotic treatments and this aggres-
sive by-product may take part in the killing mechanism of bactericidal drugs or promote muta-
genesis. Most of these studies were carried out in the iron-rich LB medium and whether
processes as described here for the interaction between an AMP and iron apply to antibiotics
remains to be explored.
Conclusions
Our results support the notion that under certain pathological situations, sub-inhibitory con-
centrations of cAMPs facilitate uncontrolled uptake of free iron by bacterial cells, which results
in increased mutagenesis by Fenton reaction (Fig 5). According to our results, this could be a
Fig 4. Mutation hotspots in glpT. Distribution of the mutations in the 1160 bp-long fragment of glpT in P. aeruginosa PA14 fosfomycin-resistant clones
treated with iron, LL-37, or a combination of both. The number of mutations (nucleotide substitutions, indels) is plotted against respective nucleotide positions
within the gene fragment. Note the overlapping mutations at positions 220–225, 409 and 524 bp in iron and LL-37 treatments and absence of common
mutations in LL-37+Fe2+ treatment. The fig was generated using the mutational spectrum analysis software iMARS [39].
doi:10.1371/journal.pgen.1005546.g004
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general mechanism underlying mutagenesis by joint action of antimicrobial peptides and free
iron in specific situations where iron is not limited.
Free iron levels are kept as low as possible due to its toxic effect for all living beings but espe-
cially in bacteria that lack proper cell compartments. In fact, iron withdrawal is part of the nat-
ural innate immune response in inflammation that makes free iron even scarcer. During
inflammation and infection a “hypoferremic response” (anaemia of inflammation) is observed
[52,53]. Many chelating proteins such as transferrin and ferritin exhibit antibacterial activity
simply by making iron availability incompatible with bacterial proliferation [54].
Despite showing that many cationic antimicrobial peptides are unable to increase mutation
rates [7], the particular situation of iron-induced mutagenesis can be of great interest for cer-
tain types of infections where iron homoeostasis is compromised. In cystic fibrosis, bleeding
happens frequently. Considering that P. aeruginosa is one of the most common pathogens that
acquire all antibiotic resistance by mutations, the mechanism proposed here is likely very rele-
vant for pathoadaptation.
Fig 5. A model for LL-37-mediated, iron–inducedmutagenesis in Pseudomonas aeruginosa. The interactions of LL-37 with the membrane at sub-
inhibitory concentrations lead to transient permeability changes in the membranes that promote iron movement in favour of the electrochemical gradient.
Uncontrolled uptake of ferrous ions stimulates Fenton reaction that leads to hydroxyl radical formation and results in DNA damage and mutagenesis.
doi:10.1371/journal.pgen.1005546.g005
Cationic Peptides and Iron Mutagenesis in Bacteria
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Finally, our work has potential implications for the development of future treatment of
chronic respiratory infections by Pseudomonas aeruginosa. For example, modulation of iron-
chelating agent in CF therapy could potentially slow down the pathoadaptation and develop-
ment of resistance in CF, and diminish lung damaging by ROS.
Materials and Methods
Bacteria and growth conditions
The P. aeruginosa PAO1 wild-type strain was kindly provided by M. A. Jacobs. The P. aerugi-
nosa PA14 was kindly provided by Nicole T. Liberati and Frederick Ausubel. All bacterial
strains were cultured in Mueller-Hinton Broth, non-cation adjusted (Sigma), with total iron
content 0.22 ± 0.02 μM, following recommendations of CLSI for cationic antimicrobial peptide
susceptibility testing. The MHB pH was adjusted to 6 in all cases with acetic acid to enhance
solubility of both, LL-37 and iron compound. All experiments were performed at 37°C, under
agitation in liquid culture. For genetic manipulation, Escherichia coli DH5α strain was used
and routinely cultured in Lysogeny Broth (LB medium), supplemented with antibiotic when
appropriate.
Minimal inhibitory concentration (MIC)
MICs were determined according to CLSI recommendations by a microdilution method with
some modifications for antimicrobial peptides. The MIC was defined as the antimicrobial con-
centration that inhibited growth after 24 hours of incubation in liquid MHB medium at 37°C.
Polypropylene non-binding multi-well plates (Th. Geyer, Germany) were used for all
experiments.
Determination of MIC50
The MIC50s for all antimicrobials were determined by inoculating strains grown to mid-log
phase into the wells of a 96-microwell plate. Approximately 102 cells from overnight cultures
of PAO1 and PA14 strains were inoculated into 50 ml tubes containing 10 ml of MBH and
incubated at 37°C with strong agitation until the mid-log phase of growth (approximately 108
cfu/ml). Then, 100 μl of 2 ×108 cells from these cultures were inoculated in each well of poly-
propylene non-binding 96-multiwell plates containing 100 μl of fresh Mueller-Hinton medium
with growing concentration of serially diluted LL-37. The plates were incubated at 37°C during
four hours with continuous agitation in a plate reader (Synergy HT, BioTeK). Four replicates
per concentration were prepared and the experiments were repeated twice. MIC50s at 4 hours
were defined as the concentrations at which 50% of growth reduction in comparison to the
control at OD600 were observed.
Estimation of mutant frequencies and mutation rates
For spontaneous-mutation rate measurements of PAO1 strain, 1/100 dilutions of overnight
cultures were inoculated into four tubes per group, each containing two ml of MHB medium.
The cultures were incubated at 37°C with strong agitation to reach ~108 cfu/ml. At this point,
appropriate concentration of LL-37, colistin, iron sulphate (FeSO4) or combinations of antimi-
crobial peptides and iron, were added to the cultures. The tubes were allowed to continue their
normal growth overnight until saturation. In the experiments with colistin, the bacterial sus-
pensions were washed twice with saline solution 0.9% NaCl before plating. The cultures were
appropriately diluted and plated on MHB agar plates with or without rifampicin (100 μg/ml).
The mutant frequency was estimated by the number of colonies growing on rifampicin divided
Cationic Peptides and Iron Mutagenesis in Bacteria
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by the number of total cfu/ml. To confirm the results, relevant concentrations were also
assayed with ten replicates to see the influence of the treatment on the population mutation
rates (the number of mutations per cell per generation). Mutation rates were calculated by
maximum verisimilitude method and data were processed using the on-line web-tool Falcor
(http://www.mitochondria.org/protocols/FALCOR.html) as recommended [55,56]. Falcor
software was used to estimate the mutant frequency too. The mutation rates for the strain
PA14 under the selected treatments were determined in the same way as described for PAO1,
but fosfomycin (128 μg/ml) was used instead of rifampicin.
Sequencing of fosfomycin resistant mutants (Fos-R) and sequence
analysis
To assess the effects of iron and antimicrobial peptides and their combination on the mutation
spectrum of P. aeruginosa strain PA14, the glpT gene of twenty randomly selected Fos-R clones
from independent cultures for each treatment group (MHB supplemented either with 40 μM
Fe2+, LL-37 (32 μg/ml) or a combination of LL-37+Fe2+ at same concentrations for both), was
amplified by colony PCR using glpT-P14-F1 (5-AGCGGAGCTCGCGATGTTC-3) and glpT-
P14-R1 (5-TCAGCCGGCTTGCTGCGG-3) primers [36] and Kapa2G Fast ReadyMix PCR
with dye kit (KAPA Biosystems, Boston, US). Cycling conditions were as follows: 95°C 7’/
(95°C 15”/60°C 15”/72°C 40”)x 35/72°C 7’/4°C hold. The PCR products were purified and
sequenced at Macrogen Europe using the forward and reverse primers described above.
Sequences were assembled using SeqTrace software. Assembled sequences were imported into
CLC Sequence Viewer 6 and aligned using default settings. Low quality flanking sequences
were removed and the alignment was trimmed to the 1160 bp fragment (the 52–1212 bp region
relative to the A in the start ATG codon of the 1347bp-long glpT ORF). A tridimensional
homology model of GlpT was generated using Cn3D software by performing a BLASTP search
using PA14 strain GlpT protein sequence as a query and mapping the resulting alignment
against the experimentally determined Escherichia coli K-12 GlpT protein structure. To evalu-
ate the potential effects of amino acid substitution on protein stability, the online tool I-Mutant
(http://gpcr2.biocomp.unibo.it/cgi/predictors/I-Mutant3.0/I-Mutant3.0.cgi) was used.
TMHMM server v. 2.0 (http://www.cbs.dtu.dk/services/TMHMM/) was used for prediction of
transmembrane helices in glpT protein sequence. Mutational spectrum differences were ana-
lysed using the software iMARS [39].
Influence of 2–20 bipyridyl on LL-37+Fe2+ mutagenesis
The effect of 2–20 bipyridyl, an iron chelating agent, on LL-37+Fe2+ mutagenesis was deter-
mined by measuring its influence on mutant frequency on a selected concentration of LL-37
+Fe2+ combination (32 μg/ml and 40 μM of Fe2+respectively), where mutagenesis was
observed. The experiment consisted of adding a titrating concentration of 2–20 bipyridyl (114
μM) to chelate 95% of the added iron of treated cultures, in order to make the treatment com-
patible with bacterial growth. Cultures with the described LL-37+Fe2+ combination with no
addition of 2–20 bipyridyl were used as a control. The mutant frequencies of both groups were
determined as described elsewhere in this section. LL-37, iron and 2–20 bipyridyl were simulta-
neously added to the exponentially growing cultures.
Cloning of dps gene and mutagenesis experiment
DNA fragment containing the PAO1 dps gen from genomic DNAs was amplified by PCR
using the oligonucleotides PA-DPS-F1 (50-ATGGAAATCAATATCGGAATCG-30) and
PA-DPS-R1 (50-CTACTCAAATCAAGCGGTTGGC-30) as forward and reverse primers,
Cationic Peptides and Iron Mutagenesis in Bacteria
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respectively. The fragment contains the ATG codon and 50 nucleotides downstream of the
stop codon. The PCR product was directly cloned into the SmaI-digested and T-tailed pUCP24
plasmid vector (replicative in both P. aeruginosa and E. coli), which harbours Gentamicin resis-
tance markers [57]. E. coli DH5α was used following standard protocols for genetic manipula-
tions. The resulting plasmids, termed pUCP24-DPS, were introduced by electroporation into
PAO1 wild type strain. The cloning vector was also transformed into the same strain as control.
An experiment similar to the one designed for 2–20 bipyridyl was carried out. A mutagenic
combination of LL-37+Fe2+ was assayed in the strains carrying pUCP24-DPS plasmid or the
empty vector pUCP24 and mutant frequencies were determined for both groups.
Quantification of iron concentrations
Total iron quantification was carried our as previously described with minor modifications
[58,59]. Cultures of P. aeruginosa PAO1 were grown to an OD600 of approximately 0.5 at 37°C
with agitation in a volume of two ml in MHB. The cultures were centrifuged at 4000 g during
ten minutes at 20°C. The pellets were re-suspended in fresh MHB and three different groups
were prepared. The treatments consisted of LL-37 (32 μg/ml) (I), iron sulphate to a final con-
centration of 40 μM (II), a combination iron sulphate and LL-37 (III), both of them at the same
concentrations of their respective group I and II, and a control group (IV) to which the propor-
tional amounts of LL-37 and iron sulphate solvent were added (sterile dH20 and dH20, pH = 5
respectively). The cultures were incubated for up to 30 minutes and harvested by centrifugation
as before but at 4°C. The cell pellets were washed twice with ice-cold phosphate-buffered saline
(PBS) and re-suspended in 1 ml of TE buffer containing 5 mg/ml of egg lysozyme (Sigma) and
incubated during 10 minutes at room temperature. To quantify total iron, the lysate (one ml)
was mixed with one ml of HCl 10 mM and 1 ml of iron-releasing reagent containing HCl 1.4
M + 4.5% (weight/volume) aqueous solution of KMnO4; 1/1 and incubated at 60°C for two
hours. After cooling, 0.06 ml iron-detection reagent (6.5 mM ferrozine, 6.5 mM neocuproine,
2.5 M ammonium acetate, 1 M ascorbic acid in water) was added and the sample absorbance
was read at 550 nm in a plate reader Synergy HT (Biotek). The iron concentrations were deter-
mined based on a standard curve obtained with increasing concentrations of ferric chloride
and normalized to protein concentration of the lysates. Each group consisted of five cultures.
We determined the content of total iron in our cultures media MHB and LB, using the same
procedure describe above, starting by the addition of 1 ml of HCl 10 mM and 1 ml of the iron-
releasing reagent. Under the suspicion that MHB had lower iron content, the samples of this
medium were prepared ten-fold concentrated.
Statistical analyses
An unpaired Student's t test or Mann-Whitney U test was used where appropriate for statistical
analysis, according to the nature of the data (parametric or nonparametric adjustment). Two-
tailed Fisher’s exact test or Monte Carlo hypergeometric test were used to calculate statistical
significance of differences in mutation frequencies at each codon site of the alignment between
treatments in the mutational spectrum analysis. P values less than 0.05 were considered statisti-
cally significant. All tests were performed with statistic software R except for mutational spec-
trum analysis where iMARS [39] was used instead.
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S5 Fig. 3D-structural model of GlpT. A homology model of GlpT was generated using
Cn3D software by performing a BLASTP search using PA14 GlpT protein sequence as a
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S6 Fig. DNA alignment of the 1160 bp fragment of glpT from twenty Fos-R P. aeruginosa
PA14 clones treated with iron, LL-37 and LL-37+Fe2+. The 52–1212 bp region relative to the
A in the start ATG codon of the 1347bp-long glpT ORF.
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S7 Fig. Mutation types in glpT. Prevalence of certain mutation types in iron, LL-37 and LL-
37+Fe2+ treatments. C to T transitions was the most common type of nucleotide substitutions
in LL-37+Fe2+ treatment, but not in two other treatments.
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S1 Table. Mutations in glpT of Fos-R P. aeruginosa PA14 clones treated with iron, LL-37
and LL-37+Fe2+.
(PDF)
S2 Table. Two-tailed Fisher's exact-test of probability of having the same mutation in both
LL-37 and iron treatments.H0 is rejected if P<0.05.
(PDF)
S3 Table. Two-tailed Fisher's exact-test of probability of having the same mutation in both
LL-37 and LL-37+Fe2+ treatments.H0 is rejected if P<0.05. Mutation hotspots that signifi-
cantly different are highlighted.
(PDF)
S4 Table. Two-tailed Fisher's exact-test of probability of having the same mutation in both
iron and LL-37+Fe2+ treatments.H0 is rejected if P<0.05. Mutation hotspots that signifi-
cantly different are highlighted.
(PDF)
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